申请人:Cottrell Kevin M.
公开号:US20110165120A1
公开(公告)日:2011-07-07
The present invention relates to compounds of formula I:
or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease.
本发明涉及式I的化合物:或其药学上可接受的盐或混合物,其抑制丝氨酸蛋白酶活性,特别是乙型肝炎病毒NS3-NS4A蛋白酶的活性。